An independent nonprofit built for the entire biospecimen ecosystem.
Our Mission
To raise awareness of the importance and opportunities of biospecimen management, develop responsible standards and best practices, and engage with regulatory authorities through efficiencies, policy, and thought leadership.
The BMC exists because these problems were created by silos. Our mission is to break them down.
Our Story
The Biospecimen Management Consortium (BMC) is a nonprofit 501(c)(6) organization founded in June 2024. We bring together sponsors, clinical and academic research sites, vendors, and partner laboratories to advance the practice of biospecimen management in clinical research.
We are the only organization in this space that unites every stakeholder, not as observers, but as active participants defining the standards, tools, and practices that will move the industry forward.
June 2024
BMC founded by biospecimen management leaders across the clinical research ecosystem.
June 2025
Formally transitioned to nonprofit 501(c)(6) status. Board of directors named.
February 2026
Membership extended to vendors, labs, and patient advocacy groups.
2026 Focus
Standardizing and aligning the protocol, biospecimen plan, and lab manual.
Our values
Every sample matters.
Each biospecimen represents a patient's contribution: their time, discomfort, and hope. We treat every sample with the rigor and respect that trust demands.
All stakeholders, one table.
Sustainable solutions require every voice. Sponsors, sites, vendors, labs, and patient advocates each bring irreplaceable perspective. None of them is peripheral.
Standardize to innovate.
Foundational standards free the industry to focus innovation where it matters most:
the science.
Engage and elevate.
We work with regulatory agencies to raise the bar for biospecimen management, bringing best practices to the table before mandates require it.
Our Leadership
BMC Board of Directors
Vice Chair
Associate Director, Clinical Trials Operations, Director, Special Projects
Yale Cancer Center
